<DOC>
	<DOCNO>NCT00777439</DOCNO>
	<brief_summary>The purpose study prescribe oral domperidone subject gastrointestinal disorder fail suffered adverse effect standard medical treatment .</brief_summary>
	<brief_title>Domperidone Refractory Gastrointestinal Disorders</brief_title>
	<detailed_description>Domperidone dopamine-2 receptor antagonist . It act prokinetic agent effect chemoreceptor trigger zone motor function stomach small intestine . It cause adverse neurological symptom excellent safety profile long-term oral administration recommend dos . In United States , domperidone approve Food Drug Administration ( FDA ) obtain routine prescription cover health care insurance plan . It also illegal write prescription subject obtain drug outside U.S. Domperidone administer legally obtain FDA Investigational New Drug ( IND ) application Institutional Review Board ( IRB ) approval . This study follow FDA IRB regulation provide domperidone subject gastrointestinal disorder fail standard therapy .</detailed_description>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<criteria>Male female Age 18 old Symptoms manifestation secondary GERD ( e.g. , persistent esophagitis , heartburn , upper airway sign symptom respiratory symptom ) , gastrointestinal motility disorder nausea , vomit , severe dyspepsia severe chronic constipation refractory standard therapy . Subjects must comprehensive evaluation eliminate cause symptom . Subject sign informed consent administration domperidone . The informed consent informs subject potential adverse event include : increase prolactin level extrapyramidal side effect breast change cardiac arrhythmia include QT prolongation potential increase risk adverse event drug list addendum History current cardiac disease , include ischemic valvular heart disease , structural heart defect , cardiomyopathy congestive heart failure . History current arrhythmia include ventricular tachycardia , ventricular fibrillation Torsade des Pointes . Subjects minor form ectopy ( PACs ) necessarily exclude . Clinically significant bradycardia , sinus node dysfunction , heart block . Prolonged QT syndrome ( QTc great 450 millisecond male , great 470 millisecond female ) family history prolong QT syndrome . Presence prolactinoma ( prolactinreleasing pituitary tumor ) . Conditions result electrolyte disorder , severe dehydration , vomit , malnutrition , eat disorder , renal disease , use potassiumwasting diuretic insulin acute setting . ( Note presence vomiting , may accompany gastroparesis pseudo obstruction exclude subject accompany electrolyte disturbance must subject exclude . ) Pregnant breast feed female . Known allergy domperidone component domperidone formulation . Significantly significant electrolyte disorder . Gastrointestinal hemorrhage obstruction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Dopamine</keyword>
	<keyword>Domperidone</keyword>
	<keyword>Gastroparesis</keyword>
	<keyword>Gastrointestinal Diseases</keyword>
	<keyword>Neurologic Manifestations</keyword>
	<keyword>Stomach Diseases</keyword>
	<keyword>Digestive System Diseases</keyword>
	<keyword>Esophagitis</keyword>
	<keyword>Esophageal Disorders</keyword>
	<keyword>Paralysis</keyword>
</DOC>